Analyst ratings, especially from reputable firms like Needham, can significantly impact investor sentiment and stock prices. The reiteration of a Buy rating and a high price target suggests strong confidence in Cytokinetics' future performance, which could lead to increased investor interest and a potential rise in stock price.